JP2009528284A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528284A5
JP2009528284A5 JP2008555763A JP2008555763A JP2009528284A5 JP 2009528284 A5 JP2009528284 A5 JP 2009528284A5 JP 2008555763 A JP2008555763 A JP 2008555763A JP 2008555763 A JP2008555763 A JP 2008555763A JP 2009528284 A5 JP2009528284 A5 JP 2009528284A5
Authority
JP
Japan
Prior art keywords
phenyl
benzimidazol
carboxylic acid
thiazole
dimethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555763A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/051541 external-priority patent/WO2007096315A1/en
Publication of JP2009528284A publication Critical patent/JP2009528284A/ja
Publication of JP2009528284A5 publication Critical patent/JP2009528284A5/ja
Pending legal-status Critical Current

Links

JP2008555763A 2006-02-27 2007-02-19 Plk1阻害剤としての4−フェニル−チアゾール−5−カルボン酸及び4−フェニル−チアゾール−5−カルボン酸アミド Pending JP2009528284A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27
PCT/EP2007/051541 WO2007096315A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Publications (2)

Publication Number Publication Date
JP2009528284A JP2009528284A (ja) 2009-08-06
JP2009528284A5 true JP2009528284A5 (enExample) 2012-06-07

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555763A Pending JP2009528284A (ja) 2006-02-27 2007-02-19 Plk1阻害剤としての4−フェニル−チアゾール−5−カルボン酸及び4−フェニル−チアゾール−5−カルボン酸アミド

Country Status (19)

Country Link
US (1) US7504513B2 (enExample)
EP (1) EP1991543A1 (enExample)
JP (1) JP2009528284A (enExample)
KR (1) KR101060539B1 (enExample)
CN (1) CN101415704A (enExample)
AR (1) AR059621A1 (enExample)
AU (1) AU2007217575A1 (enExample)
BR (1) BRPI0710473A2 (enExample)
CA (1) CA2642921A1 (enExample)
CR (1) CR10206A (enExample)
EC (1) ECSP088700A (enExample)
IL (1) IL193481A0 (enExample)
MA (1) MA30260B1 (enExample)
MX (1) MX2008010884A (enExample)
NO (1) NO20083708L (enExample)
RU (1) RU2008138163A (enExample)
TW (1) TW200745097A (enExample)
WO (1) WO2007096315A1 (enExample)
ZA (1) ZA200807074B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008149784A1 (ja) * 2007-06-08 2008-12-11 Nec Corporation 半導体集積回路及びフィルタ制御方法
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
KR101707669B1 (ko) * 2008-04-17 2017-02-16 더 존스 홉킨스 유니버시티 약제-내성 종양에서 화학요법제 활성을 증강시키는 on01910.na
WO2010029327A1 (en) * 2008-09-10 2010-03-18 Datalase Ltd. Data storage medium
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
CA2745596A1 (en) * 2008-12-18 2010-10-28 F. Hoffmann-La Roche Ag Thiazolyl-benzimidazoles
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
CN102395585A (zh) * 2009-01-30 2012-03-28 米伦纽姆医药公司 杂芳基化合物和其作为pi3k抑制剂的用途
PH12013500274A1 (en) 2010-08-11 2013-03-04 Millennium Pharm Inc Heteroaryls and uses thereof
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
EP2627181A4 (en) 2010-10-13 2014-03-19 Millennium Pharm Inc HETEROARYLE AND USES THEREOF

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
MXPA03001169A (es) 2000-08-10 2003-06-30 Pharmacia Italia Spa Biciclo-pirazoles activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos.
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
WO2003070283A2 (en) 2002-02-22 2003-08-28 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
EP1486490A1 (en) * 2002-02-28 2004-12-15 Takeda Chemical Industries, Ltd. Azole compounds
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
EP1487428B1 (en) 2002-02-28 2011-09-21 Temple University - Of The Commonwealth System of Higher Education Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
RU2004135533A (ru) 2002-05-03 2005-07-20 Шеринг Акциенгезельшафт (De) Тиазолидиноны и их применение в качестве ингибиторов polo- подобной киназы
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
RU2296758C2 (ru) * 2002-08-08 2007-04-10 Смитклайн Бичем Корпорейшн Производные тиофена
CA2506246A1 (en) 2002-11-14 2004-06-03 Massachusetts Institute Of Technology Products and processes for modulating peptide-peptide binding domain interactions
WO2004043936A1 (ja) 2002-11-14 2004-05-27 Kyowa Hakko Kogyo Co., Ltd. Plk阻害剤
WO2004054186A1 (ja) 2002-12-12 2004-06-24 Fujitsu Limited データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
US7514446B2 (en) 2003-02-20 2009-04-07 Smithkline Beecham Corporation Pyrimidine compounds
ES2326808T3 (es) 2003-04-01 2009-10-20 Smithkline Beecham Corporation Compuestos de imidazotriazina para el tratamiento de enfermedades cancerosas.
CA2529032C (en) 2003-06-24 2009-12-22 Pfizer Products Inc. Processes for the preparation of 1-[2-benzimidazol-1-yl) quinolin-8-yl] piperidin-4-ylamine derivatives
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
JP5164380B2 (ja) 2003-10-21 2013-03-21 サイクラセル リミテッド ピリミジン−4−イル−3,4−チオン化合物及び治療におけるその使用
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
WO2005075470A1 (en) 2004-01-28 2005-08-18 Smithkline Beecham Corporation Thiazole compounds

Similar Documents

Publication Publication Date Title
JP2009528284A5 (enExample)
RU2491285C2 (ru) Органические соединения
JP2009534386A5 (enExample)
CA2641473A1 (en) Condensed imidazole derivatives as aldosterone synthase inhibitors
JP2013514345A5 (enExample)
JP2007519735A5 (enExample)
JP2018524338A5 (enExample)
JP2013501720A5 (enExample)
JP2019537594A5 (enExample)
JP2014506599A5 (enExample)
RU2016111659A (ru) Соединение с агонистической активностью в отношении рецепторов соматостатина и его фармацевтическое применение
JP2013528602A5 (enExample)
JP2011502958A5 (enExample)
JP2009524670A5 (enExample)
JP2006521336A5 (enExample)
RU2011105151A (ru) Азольные соединения
JP2013507425A5 (enExample)
RU2017123114A (ru) 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов
HRP20170029T1 (hr) Derivati triazola ili njihove soli
JP2017538785A5 (enExample)
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
JP2012510989A5 (enExample)
JP2006500348A5 (enExample)
WO2006078621A3 (en) 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
JP2010540462A5 (enExample)